letters & comments

Examining Charitable Giving and Trends in the Nonprofit Sector

03/17/2022 Read More

Statement for the Record: FDA User Fee Reauthorization: Ensuring Safe and Effective Drugs and Biologics

02/03/2022 Read More

NHC Comments on HHS Notice of Benefit and Payment Parameters for 2023

01/27/2022 Read More

Letter of Support for Dr. Robert Califf FDA Commissioner Nominee

12/13/2021 Read More

NHC Comments on FDA-2020-D-2316 for Benefit-Risk Assessment for New Drug and Biological Products; Draft Guidance for Industry

11/29/2021 Read More

NHC RWE, EHR and Medical Claims Comments

11/29/2021 Read More

NHC Comments on PDUFA Reauthorization Performance Goals and Procedures FY 2023-2027

10/29/2021 Read More

CMS Physician Fee Schedule Proposed Rule

09/13/2021 Read More

Recommendations to Congress for Reconciliation Legislation

09/08/2021 Read More
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19